These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 139205

  • 1. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V, Richman SP, Benjamin RS, Burgess MA, Murphy WK, Valdivieso M, Banner RL, Gutterman JU, Bodey GP, Freireich EJ.
    Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F, Correa J, Buroker T, Vaitkevicius VK.
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract] [Full Text] [Related]

  • 3. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
    Krasnow S, Green M, Perry DJ, Eisenberger MA, Johnston-Early A, Muggia F, Cohen MH.
    Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
    [No Abstract] [Full Text] [Related]

  • 4. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC, Bundy B, Dolan T, Homesley H, DiSaia PJ.
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [Abstract] [Full Text] [Related]

  • 5. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT, Bonnet JD, Wilson H, Heilbrun LK.
    Cancer Treat Rep; 1980 Feb; 64(2-3):247-50. PubMed ID: 7407758
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM, LoBuglio A, McCracken J, Pugh R.
    Cancer Treat Rep; 1980 Feb; 64(12):1387-8. PubMed ID: 7471126
    [Abstract] [Full Text] [Related]

  • 7. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
    Rodriguez V, Gottlieb J, Burgess MA, Livingston R, Wheeler W, Spitzer G, Bodey GP, Blumenschein GR, Freireich EJ.
    Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
    [Abstract] [Full Text] [Related]

  • 8. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Bruckner HW, Lokich JJ, Stablein DM.
    Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT, O'Bryan RM, Benjamin RS, Coltman CA.
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [Abstract] [Full Text] [Related]

  • 11. Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas.
    Ajani JA, Dimery I, Chawla SP, Pinnamaneni K, Benjamin RS, Legha SS, Krakoff IH.
    Cancer Treat Rep; 1986 Mar; 70(3):375-9. PubMed ID: 3955548
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul 18; 17(15):62-3. PubMed ID: 50555
    [No Abstract] [Full Text] [Related]

  • 14. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jul 18; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.